Preventive Health News

SAN FRANCISCO — Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from a study presented at the Conference on Retroviruses and Opportunistic Infections.

Intentional weight loss of 5% or more, coupled with reduced waist circumference was associated with lower risk for death from cancer, CVD or any cause among postmenopausal women followed for more than 18 years, data show.

The addition of treatment for male partners reduced the recurrence of bacterial vaginosis among women enrolled in a randomized trial compared with treating only the women, researchers reported.

From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting recommendations for HPV vaccination at ages 11 to 12 years, researchers wrote in Morbidity and Mortality Weekly Report.

States that have adopted complete or 6-week abortion bans have “higher-than-expected” infant mortality and fertility rates, according to two studies published in JAMA.

AI-supported breast cancer screening increased early-stage cancer detection while reducing radiologists’ workload without increasing false positives, but more research is needed before clinical implementation, researchers reported.

The U.S. maternal mortality crisis is driven by various factors, but primary care providers are uniquely positioned to prevent pregnancy-related complications, according to experts.

Ulipristal acetate followed by misoprostol was effective and acceptable for medication abortion up to 63 days’ gestation with no serious adverse events, but more studies are needed, data from a proof-of-concept study show.

Fewer than half of women who tested positive for HPV with negative cytological findings returned for a surveillance co-test within 1 year as recommended, yet more than half of those who received testing had HPV persistence or progression.